X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer

X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer

The allure of potentially dramatic and durable responses to immunotherapy has driven the study of several immune checkpoint inhibitor (ICI) agents in ovarian cancer. However, the results of ICI therapy in ovarian cancer have been rather disappointing. It is important to understand the reasons for th...

Full description

Bibliographic Details
Main Authors: Yanhui Jiang, Lewei Yang, Ling Jiang, Wenyan Yu, Zhongwen Jin, Yeqing Qiu, Yifeng Liao, Jihong Liu, Hongyu Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Genetics
Subjects:
XBP1
immune checkpoint
immunogenic cell death
genomic alteration
bioinformatics analysis
ovarian cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.818917/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.818917/full

Similar Items